Nanoparticles Encapsulating Chemotherapy Drugs to Kill Triple Negative Breast Cancer

The cells of triple negative breast cancer tumors don’t have receptors for estrogen, progesterone, and HER2, the main targets used to attack breast cancers. This is why they’re so difficult to treat, but researchers at George Washington University have shown that a technique of delivering a chemotherapy agent within specially designed (Read more...)

Full Story →